Posted On: 10/23/2015 12:15:31 PM
Post# of 72446
From CTIX Facebook:
"The Company is now actively engaged in writing a grant application in partnership with physicians at one of the most renowned hospitals in the US for a Phase 2 trial of Kevetrin for pancreatic cancer. Therefore we study these releases carefully and compare them to our knowledge of Kevetrin. At this time we are moving fast forward to compile all data necessary for the submission deadline in January 2016."
http://www.fda.gov/NewsEvents/Newsroom/PressA...468654.htm
"The Company is now actively engaged in writing a grant application in partnership with physicians at one of the most renowned hospitals in the US for a Phase 2 trial of Kevetrin for pancreatic cancer. Therefore we study these releases carefully and compare them to our knowledge of Kevetrin. At this time we are moving fast forward to compile all data necessary for the submission deadline in January 2016."
http://www.fda.gov/NewsEvents/Newsroom/PressA...468654.htm
(0)
(0)
